BXP vs CODX
Boston Properties Inc (BXP) versus Co-Diagnostics, Inc. Common Stock (CODX) — a side-by-side from cached financials, not a winner call.
Boston Properties Inc (BXP) is a reit - office company listed on US.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Latest reported BXP revenue for 2024-12-31 was $3.41B. Net income was $84.2M. Revenue was up 4.1% from 2023-12-31 to 2024-12-31. BXP currently screens at market cap $12.12B.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
BXP currently screens at market cap $12.12B. CODX currently screens at market cap $31.4M.
Not investment advice. Open the BXP and CODX stock pages for the full models.
Not investment advice.